Lung Cancers Completed Phase 1 Trials for Imatinib (DB00619)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00052494Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung CancerTreatment
NCT00045604Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerTreatment